EcoDrugPlus

Ensembl ID : ENSDNOG00000048125
Gene Symbol: -
1 Cross references
248 Possible Orthologues:

Ensembl ID : ENSDNOG00000048065
Gene Symbol: -
1 Cross references
155 Possible Orthologues:

Ensembl ID : ENSDNOG00000046870
Gene Symbol: -
1 Cross references
138 Possible Orthologues:

Ensembl ID : ENSDNOG00000046530
Gene Symbol: -
1 Cross references
152 Possible Orthologues:

Ensembl ID : ENSDNOG00000043295
Gene Symbol: -
1 Cross references
215 Possible Orthologues:

Ensembl ID : ENSDNOG00000043023
Gene Symbol: -
1 Cross references
153 Possible Orthologues:

Ensembl ID : ENSDNOG00000042792
Gene Symbol: -
1 Cross references
225 Possible Orthologues:

Ensembl ID : ENSDNOG00000042784
Gene Symbol: -
1 Cross references
201 Possible Orthologues:

Ensembl ID : ENSDNOG00000040632
Gene Symbol: -
1 Cross references
723 Possible Orthologues:

Ensembl ID : ENSDNOG00000048949
Gene Symbol: -
1 Cross references
132 Possible Orthologues:

Ensembl ID : ENSDNOG00000048044
Gene Symbol: -
1 Cross references
337 Possible Orthologues:

Ensembl ID : ENSDNOG00000047869
Gene Symbol: -
1 Cross references
250 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).